相关实验视频

Updated: Jun 17, 2025

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

Published on: June 9, 2018

在遗传性转基因氨基粉症中新兴的多系统生物标志物:试点研究

Marco Luigetti^1,2, Francesca Vitali³, Angela Romano⁴

¹Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168, Rome, Italy. mluigetti@gmail.com.

Scientific reports

|August 7, 2024

概括

新的生物标志物,生长差异化因子-15 (GDF-15) 和尿素 (Umod),显示在遗传性转基因氨基粉症 (ATTRv) 中的水平发生变化. 这些发现可能有助于诊断和监测这种罕见的渐进性疾病.

科学领域:

生物化学生物化学
遗传学是一个遗传学.
腎臟病學 (nephrology) 是一種醫學.

背景情况:

遗传性转基因氨基粉症 (ATTRv) 是一种由TTR基因变异引起的渐进性多系统性疾病.
在ATTRv中早期诊断和疾病监测需要可靠的生物标志物.
目前的标志物可能无法完全捕捉疾病的严重程度和进展.

研究的目的:

评估GDF-15和Umod的血清度,作为ATTRv.中的潜在生物标志物.
评估GDF-15和Umod与已确定的疾病严重程度标志物的相关性.
研究GDF-15,Umod和功能指标之间的关系.

主要方法:

分析了来自16名ATTRv患者和26名健康对照者的血清样本.
测量了GDF-15和Umod水平,并在各组之间进行了比较.
研究了与FAP阶段,PND得分,eGFR和cystatin C的相关性.

主要成果:

与对照组相比,ATTRv患者的血清GDF-15水平明显高,血清Umod水平较低.
血清Umod与eGFR正相关,与cystatin C相反相关.
血清GDF-15与eGFR负相关,与cystatin C正相关.

结论:

血清GDF-15和Umod水平在遗传性转基因氨基粉症中发生变化.
这些生物标志物可能为ATTRv的疾病状况和功能提供了洞察力.
需要进一步的研究来验证它们在ATTRv管理中的临床实用性.

关键词:

生物标志物生物标志物氨酸C 氨酸C 是一种氨酸.估计的淋巴膜过率.增长差异化因子-15-15 遗传性转基因氨基粉症.乌罗莫杜林是一种制剂.

更多相关视频

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging

Published on: October 20, 2017

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation

Published on: February 10, 2023

相关概念视频

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...